What a COVID-19 Vaccine Rollout Means for the Economy

Author:
Publish date:
Video Duration:
2:20

Pfizer and BioNTech's vaccine was approved by the U.K.

The decision by the U.K. to approve the vaccine for emergency use came ahead of expected approvals from the U.S. and the European Union.

The shot will be available to the first round of eligible people in Britain starting next week.

Historic day! In the U.K., we received the 1st regulatory authorization of Pfizer and BioNTech’s COVID19 vaccine. I applaud the Medicines and Healthcare Products Regulatory Agency for its swift & thorough review of our vaccine data & grateful for the trust they have placed in our science," Pfizer CEO Alber Bourla wrote on Twitter. 

Jim Cramer said the Pfizer news isn't "being greeted as it should by the stock market," as all three major indices traded lower in intraday trading Wednesday.

This means that the vaccine--which has applied for an emergency use authorization with the Food and Drug Administration--could be rolled out to the U.S. population. 

Eric Winograd, senior economist at AllianceBernstein, joined TheStreet to talk about how a vaccine rollout could impact the economy. 

You can follow Katherine Ross on Twitter at @byKatherineRoss.

Read more from Katherine Ross here.

Latest Videos From TheStreet and Jim Cramer:

Related Videos